Literature DB >> 9175947

Randomised trial of dopamine compared with hydrocortisone for the treatment of hypotensive very low birthweight infants.

D Bourchier1, P J Weston.   

Abstract

AIM: To compare the efficacy of hydrocortisone with dopamine for the treatment of hypotensive, very low birthweight (VLBW) infants.
METHODS: Forty infants were randomly allocated to receive either hydrocortisone (n = 21) or dopamine (n = 19).
RESULTS: All 19 infants randomised to dopamine responded; 17 of 21 (81%) did so in the hydrocortisone group. Three of the four non-responders in the hydrocortisone group had clinically significant left to right ductal shunting. The incidence of bronchopulmonary dysplasia, retinopathy of prematurity, intraventricular haemorrhage, necrotising enterocolitis, symptomatic patent ductus arteriosus, hyperglycaemia, sepsis (bacterial or fungal) or survival did not differ between groups. The adrenocorticotrophic hormone (ACTH) stimulated plasma cortisol activity, either before or after treatment, did not differ between the two groups of infants. Although a significant difference in efficacy between dopamine and hydrocortisone was not noted (P = 0.108), there were four treatment failures in the hydrocortisone group, compared with none in the dopamine group.
CONCLUSION: Both hydrocortisone and dopamine are effective treatments for hypotension in very low birthweight infants.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9175947      PMCID: PMC1720650          DOI: 10.1136/fn.76.3.f174

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN: 1359-2998            Impact factor:   5.747


  37 in total

1.  Blood pressure and cerebral haemorrhage and ischaemia in very low birthweight infants.

Authors:  A M Watkins; C R West; R W Cooke
Journal:  Early Hum Dev       Date:  1989-05       Impact factor: 2.079

2.  Mechanism of hydrocortisone potentiation of responses to epinephrine and norepinephrine in rabbit aorta.

Authors:  S Kalsner
Journal:  Circ Res       Date:  1969-03       Impact factor: 17.367

3.  The effects of dopamine infusion on regional blood flow in newborn lambs.

Authors:  T F Feltes; T N Hansen; C G Martin; A L Leblanc; S Smith; M E Giesler
Journal:  Pediatr Res       Date:  1987-02       Impact factor: 3.756

4.  Mean arterial blood pressure and neonatal cerebral lesions.

Authors:  V M Miall-Allen; L S de Vries; A G Whitelaw
Journal:  Arch Dis Child       Date:  1987-10       Impact factor: 3.791

5.  Fetal heart rate, arterial pressure, and blood volume responses to cortisol infusion.

Authors:  C E Wood; C Y Cheung; R A Brace
Journal:  Am J Physiol       Date:  1987-12

6.  Mean arterial blood pressure changes in premature infants and those at risk for intraventricular hemorrhage.

Authors:  H S Bada; S B Korones; E H Perry; K L Arheart; J D Ray; M Pourcyrous; H L Magill; W Runyan; G W Somes; F C Clark
Journal:  J Pediatr       Date:  1990-10       Impact factor: 4.406

7.  Response to ACTH in the newborn.

Authors:  S Thomas; J F Murphy; J Dyas; M Ryalls; I A Hughes
Journal:  Arch Dis Child       Date:  1986-01       Impact factor: 3.791

Review 8.  Beta-adrenoceptor regulation in the human heart: can it be monitored in circulating lymphocytes?

Authors:  O E Brodde; M C Michel; E P Gordon; A Sandoval; E M Gilbert; M R Bristow
Journal:  Eur Heart J       Date:  1989-06       Impact factor: 29.983

9.  Cardiovascular response to dopamine in hypotensive preterm neonates with severe hyaline membrane disease.

Authors:  I Seri; T Tulassay; J Kiszel; T Machay; S Csömör
Journal:  Eur J Pediatr       Date:  1984-04       Impact factor: 3.183

10.  A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia.

Authors:  J J Cummings; D B D'Eugenio; S J Gross
Journal:  N Engl J Med       Date:  1989-06-08       Impact factor: 91.245

View more
  23 in total

Review 1.  Corticosteroids for treating hypotension in preterm infants.

Authors:  Hafis Ibrahim; Ian P Sinha; Nimish V Subhedar
Journal:  Cochrane Database Syst Rev       Date:  2011-12-07

2.  Clinical detection of low upper body blood flow in very premature infants using blood pressure, capillary refill time, and central-peripheral temperature difference.

Authors:  D A Osborn; N Evans; M Kluckow
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2004-03       Impact factor: 5.747

Review 3.  Which inotrope for which baby?

Authors:  N Evans
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2006-05       Impact factor: 5.747

Review 4.  Management of Shock in Neonates.

Authors:  B Vishnu Bhat; Nishad Plakkal
Journal:  Indian J Pediatr       Date:  2015-05-21       Impact factor: 1.967

Review 5.  Early volume expansion versus inotrope for prevention of morbidity and mortality in very preterm infants.

Authors:  D A Osborn; N Evans
Journal:  Cochrane Database Syst Rev       Date:  2001

6.  Refractory hypotension in preterm infants with adrenocortical insufficiency.

Authors:  P C Ng; C W Lam; T F Fok; C H Lee; K C Ma; I H Chan; E Wong
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-03       Impact factor: 5.747

7.  Population pharmacokinetics of unbound hydrocortisone in critically ill neonates and infants with vasopressor-resistant hypotension.

Authors:  Heather E Vezina; Chee M Ng; Delia M Vazquez; John D Barks; Varsha Bhatt-Mehta
Journal:  Pediatr Crit Care Med       Date:  2014-07       Impact factor: 3.624

8.  An evaluation of hydrocortisone dosing for neonatal refractory hypotension.

Authors:  E S Peeples
Journal:  J Perinatol       Date:  2017-05-18       Impact factor: 2.521

9.  Transient adrenocortical insufficiency of prematurity and systemic hypotension in very low birthweight infants.

Authors:  P C Ng; C H Lee; C W K Lam; K C Ma; T F Fok; I H S Chan; E Wong
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2004-03       Impact factor: 5.747

Review 10.  Early volume expansion for prevention of morbidity and mortality in very preterm infants.

Authors:  D A Osborn; N Evans
Journal:  Cochrane Database Syst Rev       Date:  2004
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.